Molex LLC-医療機器分野:企業M&A・提携分析

◆英語タイトル:Molex LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011059
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex’s product portfolio includes switches, integrated products, electrical and fiber optic interconnection products and systems, and connectors. The company’s customer base includes original equipment manufacturers (OEM’s), contract manufacturers and distributors. Molex offers its products and services to a wide set of industries including business equipments, automotive, computer peripherals, consumer products, industrial equipment and telecommunications. Molex has operations spanned across North America, Europe, Africa, Middle East, Latin America and Asia Pacific region. Molex is headquartered at Lisle, Illinois, the US.

Molex LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Molex LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Molex LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Molex LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Molex LLC, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Molex LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Molex LLC, Medical Equipment, Deal Details 11
Private Equity 11
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 11
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 12
Partnerships 14
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 14
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 15
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 16
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 17
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 18
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 19
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 21
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 22
Acquisition 23
Flexicare Medical Acquires Medisize 23
Molex Acquires Phillips-Medisize 24
Phillips-Medisize Acquires Medicom Innovation Partner 25
Molex Acquires ProTek Medical 26
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
ProTek Medical Acquires AP Design, Medical Device Design Company 29
Molex Acquires Affinity Medical Technologies, Maker Of Medical Interconnect Products 30
Molex LLC – Key Competitors 31
Molex LLC – Key Employees 32
Molex LLC – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Product News 35
Sep 21, 2016: Molex Continues to Bring Innovative Medical Electronic Solutions to the Marketplace 35
Other Significant Developments 36
Feb 09, 2016: Molex Expands Its Medical Business With Innovative New Capabilities 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Molex LLC, Medical Equipment, Key Facts 2
Molex LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Molex LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Molex LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Molex LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Molex LLC, Deals By Market, 2011 to YTD 2017 8
Molex LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 11
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 12
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 14
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 15
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 16
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 17
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 18
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 19
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 21
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 22
Flexicare Medical Acquires Medisize 23
Molex Acquires Phillips-Medisize 24
Phillips-Medisize Acquires Medicom Innovation Partner 25
Molex Acquires ProTek Medical 26
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
ProTek Medical Acquires AP Design, Medical Device Design Company 29
Molex Acquires Affinity Medical Technologies, Maker Of Medical Interconnect Products 30
Molex LLC, Key Competitors 31
Molex LLC, Key Employees 32
Molex LLC, Subsidiaries 33

★海外企業調査レポート[Molex LLC-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Ensign Group Inc (ENSG):製薬・医療:M&Aディール及び事業提携情報
    Summary The Ensign Group Inc (Ensign Group) is a healthcare service provider that offers patient care services. The organization offers post-acute care services including assisted living, skilled nursing, rehabilitative care, home health, home care, and hospice. It provides services such as medical, …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • PharmaCyte Biotech Inc (PMCB):企業の財務・戦略的SWOT分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • PMA Companies, Inc.:企業の戦略・SWOT・財務情報
    PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Senhwa Biosciences Inc (6492):製薬・医療:M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • Darling Ingredients Inc.:企業のM&A・事業提携・投資動向
    Darling Ingredients Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Darling Ingredients Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • iiNet Limited:企業の戦略・SWOT・財務情報
    iiNet Limited - Strategy, SWOT and Corporate Finance Report Summary iiNet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Jiuzhitang Co Ltd (000989):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiuzhitang Co Ltd (Jiuzhitang), formerly Labor Jiuzhitang Pharmacy, is a Chinese medicine manufacturing company. The company offers products such as shuxuetong injection, lujiao granule, liuwei dihuang wan pills, zuguang power, siqikang injection, luo hua zi zhu tablets, compound jiangzhi ta …
  • Reliance Capital Ltd:企業のM&A・事業提携・投資動向
    Reliance Capital Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Capital Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Windtree Therapeutics Inc (WINT):医療機器:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Newalta Corp (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆